Sodium Polystyrene Sulfonate
- Product NDC
- 10135-146
- 11-digit product format
- 101350146
- Labeler code
- 10135
- Product ID
- 10135-146_ecacd022-39ae-3536-e053-2995a90a0221
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- sodium polystyrene sulfonate
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL; RECTAL
- Labeler
- Marlex Pharmaceuticals Inc
- Application
- ANDA204071
- Marketing category
- ANDA
- Marketing start
- 2016-03-01
- Marketing end
- 0000-00-00
- Substance
- SODIUM POLYSTYRENE SULFONATE
- Active strength
- 4 meq/g
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10135-146-14 | Sodium Polystyrene Sulfonate | 15 g in 1 BOTTLE, PLASTIC | POWDER, FOR SUSPENSION | 15 | | 7 |
| 10135-146-17 | Sodium Polystyrene Sulfonate | 454 g in 1 JAR | POWDER, FOR SUSPENSION | 454 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10135-146 | SODIUM POLYSTYRENE SULFONATE POWDER, FOR SUSPENSION [MARLEX PHARMACEUTICALS INC] | 7 | Legacy NDC, 2 package rows | 20241019_3423d014-4c35-441a-8528-2a7bc050f809.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 10135-146-14 | 10135014614 | 15 g in 1 BOTTLE, PLASTIC (10135-146-14) | 15 g | 2016-03-01 | 0000-00-00 | No | No | Current |
| 10135-146-17 | 10135014617 | 454 g in 1 JAR (10135-146-17) | 454 g | 2016-03-01 | 0000-00-00 | No | No | Current |